Oxycontin ER 20 MG tablet 100S
Ended Awarded
- Contract number
- SPE2DR26F3N4U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,645
Award facts
- Contract value 100% obligated
- $1,645.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) valued at $1,645.35 with a firm fixed price structure. The award, issued on November 20, 2025, with an ultimate completion date of November 21, 2025, represents a non-competitive delivery against an existing contract vehicle. The place of performance is the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026, which serves as the primary pharmaceutical supply vehicle for federal military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a critical role in supporting military and veteran healthcare procurement through the Defense Logistics Agency. The company's federal portfolio encompasses a broad range of pharmaceutical products and medical supplies delivered under competitive, non-set-aside contract awards. This particular delivery order for controlled pharmaceutical products reflects the vendor's established capability to fulfill specialized medical supply requirements for the Defense Health Agency and other federal healthcare systems. The transaction demonstrates the operational flexibility of the DLA's pharmaceutical supply chain in procuring both routine and specialized medications to support military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F3N4U?
SPE2DR26F3N4U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26F3N4U worth?
The government has obligated $1,645 on SPE2DR26F3N4U.
Is contract SPE2DR26F3N4U an order under another contract?
Yes. SPE2DR26F3N4U is a delivery order under SPE2DR25D3008, an indefinite delivery contract.
Was contract SPE2DR26F3N4U competed?
The extent of competition for SPE2DR26F3N4U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award